Manar G. Helal 2019. Empagliflozin attenuates cyclophosphamide-induced hepatotoxicity via targeting Nrf2/HO-1 signaling, oxidative stress, and inflammation. World Journal of Pharmaceutical Sciences. 7, 11 (Nov. 2019), 49–59.